Mounjaro and Pregnancy: the Guidance, the Gaps, and What to Do Next

If you discover you are pregnant while taking Mounjaro

Stop the injection and contact your GP or midwifery team straight away. This is the single most important step. The instinct to wait and see, or to finish a current pen, is understandable, but it is the wrong call here. Animal data included in Mounjaro's prescribing information showed foetal harm at exposures comparable to those used clinically, and there is simply no robust human pregnancy safety dataset yet. The guidance on using Mounjaro during pregnancy sets this out in detail, but the short version is: stop now, tell your doctor today.

You will not be the first person this has happened to. Accidental pregnancies do occur on Mounjaro, partly because the medicine can interact with oral contraceptive absorption in a way that reduces pill effectiveness at certain points in treatment, more on that below. If this is your situation, the dedicated page for accidental pregnancy on Mounjaro covers exactly what to expect from that conversation with your GP. Stopping the medicine promptly does not guarantee safety, but it is the right first action, and your clinical team will take it from there.

One thing worth clearing up gently: some people assume that because tirzepatide leaves the body within a few weeks, restarting quickly after a miscarriage or termination is fine. It is not that simple. Your prescriber needs to reassess you fully before treatment restarts, factoring in your current health, hormonal state, and contraception plan.

Contraception while on Mounjaro: the detail that matters

The NHS advises that women taking oral contraceptive pills should use an additional, non-oral method of contraception (condoms, for example) during the first four weeks of starting Mounjaro, and for four weeks after every dose increase. The reason is mechanical: tirzepatide slows gastric emptying, which changes how quickly the pill is absorbed. Levels may be lower than expected during these transition windows, and the degree of effect varies between individuals. This is specific to tirzepatide; the equivalent concern has not been demonstrated for semaglutide in the same way. You can read the NHS England weight-management injections guidance for the full contraception advice in context.

Progestogen-only pills may be affected too, though evidence is less clear. The safest approach (and what UK clinical guidance points toward) is a non-oral method during those windows, not a different pill. Contraceptive patches, rings, implants, IUDs and injections are unaffected by gastric-emptying changes. If you are unsure what you use, or how your current contraception fits with Mounjaro's titration schedule, that question is exactly what a prescriber review is for. Our frequently asked questions address some of the practical scenarios around this.

Planning a pregnancy: when to stop and what the washout period means

If you are not pregnant now but want to be, the question becomes when to stop Mounjaro and how long to wait. The current clinical position, based on the SmPC and referenced in NHS guidance on tirzepatide, is that tirzepatide should be stopped at least one month before attempting to conceive. This is the minimum. Some prescribers and specialists recommend a longer pause, particularly if you have been on a higher maintenance dose.

The rationale is not purely pharmacokinetic, tirzepatide's half-life means it clears from the body relatively quickly for a once-weekly medicine. The concern is partly about what happens to weight during and after stopping. Rebound appetite can return, and weight regain is common after stopping GLP-1 medicines. How you manage that period, nutritionally and medically, matters for both your health and a potential pregnancy. These are conversations to have with your GP or a specialist, not something to resolve alone. If PCOS is part of your picture, the relationship between Mounjaro, ovulation and fertility is explored further on the Mounjaro, PCOS and pregnancy page, it is a nuanced area with some genuinely promising but still early evidence.

Returning to Mounjaro after pregnancy or breastfeeding

Mounjaro is not suitable while breastfeeding, it is not known whether tirzepatide passes into breast milk or what effect it might have on a nursing infant. The guidance is to avoid it until breastfeeding has stopped. After that, restarting is a clinical decision. Your prescriber will want to know your current weight, any changes in your health during pregnancy, your contraception plan going forward, and whether the original treatment indication still applies.

Returning to treatment is not automatic, and it should not be. The guidance on resuming Mounjaro after pregnancy walks through what that reassessment typically involves. If you are considering treatment for the first time after pregnancy-related weight changes, our free consultation is the starting point, a GPhC-registered prescriber reviews your case personally, and that review is where suitability is properly determined. For a broader look at what treatment involves before getting to that point, the Mounjaro overview covers the evidence, eligibility and how a private prescription works in the UK.